← Back to all trials
Completed
NCT07759518
Letrozole High Dose (10 mg) Compared to Letrozole Low Dose( 5 mg) for Ovarian Stimulation in Infertile Women With Polycystic Ovary Syndrome
Conditions: PCOS
Sex: Female
Ages: 18 Years – 35 Years
Healthy volunteers: No
Phase: NA
Enrollment: 86
Sponsor: Mst.Sumyara Khatun
Location: Bangladesh Medical University Dhaka
Summary
The goal of this clinical trial is to learn if drug letrozole 10mg for 5 days works better than letrozole 5mg for 5 days for ovarian stimulation in infertile women with PCOS. It will also learn about the safety of drug letrozole . The main questions it aims to answer are:
What medical problems do participants have when taking drug letrozole? Researchers will compare drug letrozole 10mg for 5 days works better than letrozole 5 mg for 5 days for ovarian stimulation in infertile women with PCOS
Participants will:
The experimental arm (p1) will be treated with letrozole 10 mg for 5 days. The comparator arm (p2) will receive letrozole 5 mg for 5 days for ovulation induction for consecutive 3 months Treatment will start from the 2nd day of menstruation cycle or withdrawal bleeding after the baseline visit and investigations.
Ovarian response will be assessed by trans-vaginal monitoring of follicle growth around day 10 of menstrual cycle
Eligibility Criteria
Inclusion Criteria:
1. Age: 18-35 years old
2. BMI : 18-30 kg/m2
3. Diagnosed cases of PCOS patients according to Rotterdam criteria.
4. Corrected hypothyroidism and hyperprolactinemia
Exclusion criteria:
1. Women with other infertility factors (endometriosis, tubal and uterine causes of infertility)
2. Male factor infertility
3. Impaired hepatic or renal function
4. History of hypersensitivity to letrozole
\-
\-
Source: ClinicalTrials.gov (NCT07759518). StuddyBuddy aggregates publicly available trial information.